vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and TECHPRECISION CORP (TPCS). Click either name above to swap in a different company.
Arcellx, Inc. is the larger business by last-quarter revenue ($8.1M vs $7.1M, roughly 1.1× TECHPRECISION CORP). TECHPRECISION CORP runs the higher net margin — -20.8% vs -766.0%, a 745.3% gap on every dollar of revenue. On growth, TECHPRECISION CORP posted the faster year-over-year revenue change (-6.9% vs -79.3%). TECHPRECISION CORP produced more free cash flow last quarter ($-827.0K vs $-63.9M). Over the past eight quarters, TECHPRECISION CORP's revenue compounded faster (-9.2% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
TechPrecision Corp is a manufacturer of custom high-precision metal fabricated components and integrated systems, serving aerospace, defense, medical technology, renewable energy, and industrial end markets primarily across North America and Europe. It specializes in producing tight-tolerance, mission-critical parts that adhere to rigorous industry quality requirements.
ACLX vs TPCS — Head-to-Head
Income Statement — Q1 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $7.1M |
| Net Profit | $-62.3M | $-1.5M |
| Gross Margin | — | 5.4% |
| Operating Margin | -847.6% | -19.1% |
| Net Margin | -766.0% | -20.8% |
| Revenue YoY | -79.3% | -6.9% |
| Net Profit YoY | -765.1% | -84.4% |
| EPS (diluted) | $-1.13 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $7.1M | ||
| Q3 25 | — | $9.1M | ||
| Q2 25 | — | $7.4M | ||
| Q1 25 | $8.1M | $9.5M | ||
| Q4 24 | $15.3M | $7.6M | ||
| Q3 24 | $26.0M | $8.9M | ||
| Q2 24 | $27.4M | $8.0M | ||
| Q1 24 | $39.3M | $8.6M |
| Q4 25 | — | $-1.5M | ||
| Q3 25 | — | $825.0K | ||
| Q2 25 | — | $-597.0K | ||
| Q1 25 | $-62.3M | $112.0K | ||
| Q4 24 | $-47.1M | $-799.0K | ||
| Q3 24 | $-25.9M | $-601.0K | ||
| Q2 24 | $-27.2M | $-1.5M | ||
| Q1 24 | $-7.2M | $-5.1M |
| Q4 25 | — | 5.4% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 14.0% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 14.3% |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | -6.3% | ||
| Q1 25 | -847.6% | 3.9% | ||
| Q4 24 | -348.2% | -9.1% | ||
| Q3 24 | -129.1% | -5.5% | ||
| Q2 24 | -127.8% | -16.8% | ||
| Q1 24 | -40.3% | -28.6% |
| Q4 25 | — | -20.8% | ||
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | -8.1% | ||
| Q1 25 | -766.0% | 1.2% | ||
| Q4 24 | -308.4% | -10.5% | ||
| Q3 24 | -99.4% | -6.7% | ||
| Q2 24 | -99.3% | -18.3% | ||
| Q1 24 | -18.3% | -59.5% |
| Q4 25 | — | $-0.15 | ||
| Q3 25 | — | $0.08 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | $-1.13 | $0.01 | ||
| Q4 24 | $-0.87 | $-0.08 | ||
| Q3 24 | $-0.48 | $-0.06 | ||
| Q2 24 | $-0.51 | $-0.16 | ||
| Q1 24 | $-0.14 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $50.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $416.9M | $8.0M |
| Total Assets | $648.1M | $32.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $50.0K | ||
| Q3 25 | — | $220.0K | ||
| Q2 25 | — | $143.0K | ||
| Q1 25 | $543.3M | $195.0K | ||
| Q4 24 | $587.4M | $165.0K | ||
| Q3 24 | $574.3M | $132.0K | ||
| Q2 24 | $516.7M | $44.8K | ||
| Q1 24 | $573.9M | $138.0K |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $3.0K | ||
| Q4 24 | — | $19.0K | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $8.0M | ||
| Q3 25 | — | $9.1M | ||
| Q2 25 | — | $8.2M | ||
| Q1 25 | $416.9M | $8.7M | ||
| Q4 24 | $454.8M | $8.1M | ||
| Q3 24 | $483.0M | $8.9M | ||
| Q2 24 | $487.2M | $7.9M | ||
| Q1 24 | $496.6M | $7.8M |
| Q4 25 | — | $32.8M | ||
| Q3 25 | — | $33.8M | ||
| Q2 25 | — | $32.1M | ||
| Q1 25 | $648.1M | $33.5M | ||
| Q4 24 | $711.3M | $32.2M | ||
| Q3 24 | $764.9M | $35.0M | ||
| Q2 24 | $734.3M | $35.7M | ||
| Q1 24 | $779.7M | $34.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $183.0K |
| Free Cash FlowOCF − Capex | $-63.9M | $-827.0K |
| FCF MarginFCF / Revenue | -786.4% | -11.7% |
| Capex IntensityCapex / Revenue | 9.6% | 14.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | $-4.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $183.0K | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | — | $646.0K | ||
| Q1 25 | $-63.1M | $396.0K | ||
| Q4 24 | $-46.0M | $-570.0K | ||
| Q3 24 | $30.7M | $-532.0K | ||
| Q2 24 | $-36.2M | $107.0K | ||
| Q1 24 | $-31.9M | $-452.0K |
| Q4 25 | — | $-827.0K | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | $-604.0K | ||
| Q1 25 | $-63.9M | $-930.0K | ||
| Q4 24 | $-47.5M | $-1.7M | ||
| Q3 24 | $28.4M | $-2.0M | ||
| Q2 24 | $-39.5M | $-94.0K | ||
| Q1 24 | $-38.3M | $-900.0K |
| Q4 25 | — | -11.7% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | -8.2% | ||
| Q1 25 | -786.4% | -9.8% | ||
| Q4 24 | -311.3% | -22.9% | ||
| Q3 24 | 109.2% | -21.8% | ||
| Q2 24 | -144.1% | -1.2% | ||
| Q1 24 | -97.7% | -10.5% |
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 11.0% | ||
| Q2 25 | — | 16.9% | ||
| Q1 25 | 9.6% | 14.0% | ||
| Q4 24 | 9.8% | 15.4% | ||
| Q3 24 | 8.8% | 15.9% | ||
| Q2 24 | 11.7% | 2.5% | ||
| Q1 24 | 16.4% | 5.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.54× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACLX
Segment breakdown not available.
TPCS
| Defense | $6.7M | 94% |
| Other | $410.0K | 6% |
